Evidence map›Paper›PMID 38868118›Full record

ArticleClinical case reports2024

Radiotherapeutic outcomes of Rosai-Dorfman disease with falx cerebri and superior sagittal sinus involvement: A rare case report with long-term follow-up.

Hamid Nasrollahi, Susan Andalibi, Mansour Ansari, Maral Mokhtari, Ehsan Mohammad Hosseini, Mina Foroughi, Arman Sourani

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hamid NasrollahiDepartment of Radiation Oncology Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-7423-3312
Susan AndalibiDepartment of Radiation Oncology Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0009-0006-3800-1035
Mansour AnsariDepartment of Radiation Oncology Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-8249-1776
Maral MokhtariDepartment of Pathology Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-4815-2631
Ehsan Mohammad HosseiniDepartment of Neurosurgery, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-9786-9954
Mina ForoughiIsfahan Medical Students' Research Committee (IMSRC) Isfahan University of Medical Sciences Isfahan Iran.ORCID https://orcid.org/0000-0001-6640-7493
Arman SouraniDepartment of Neurosurgery, School of Medicine Isfahan University of Medical Sciences Isfahan Iran.ORCID https://orcid.org/0000-0002-8998-9446

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Intracranial RDD is rare medical event mimicking different diagnoses. Although the surgical resection is the best treatment option, but radiation therapy can also achieves long-term suboptimal outcomes. Abstract: An 83-year-old male with a history of tension-type headaches was evaluated. He was conscious with no focal neurological deficits. His brain MRI revealed an enhancable bifrontal tumor originating from falx cerebri and superior sagittal sinus dura. Due to the patient's preference and decline for gross total resection, she underwent a stereotactic biopsy. The pathology was positive for Rosai-Dorfman diseases. He received definitive targeted radiation with a total dose of 4500 cGy administered in 200 cGy daily fractions. His 4-year follow-up showed regional tumor control with excellent neurological outcome.

Indexed as

brain tumorslymphoproliferative diseasesRosai–Dorfman diseasesinus histiocytosis with massive lymphadenopathystereotactic biopsytargeted radiotherapy

Identifiers

PMID38868118
PMCPMC11166549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.